Trastuzumab Rezetecan
26-OBU-JS-BC-II-017
Approved small_molecule active
Quick answer
Trastuzumab Rezetecan for Breast Cancer is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Breast Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active